Pernod downplays US slowdown amid Brown-Forman talks

Pernod Ricard reported Q3 organic net sales growth of 0.1% to €1.94 billion, but the US fell 12% and first-nine-month organic sales were down 4.4%, led by a 14% decline in the US. Management said the US spirits market remains soft due to affordability pressures and expects full-year US sales to be much worse than underlying trends, while also noting ongoing discussions with Brown-Forman. The company now expects Middle East conflict to reduce full-year organic sales by 3% to 4% and sees global travel retail in slight decline.

Analysis

The important read-through is not just weak US demand, but a likely mix-shift inside the category that should favor premium-plus incumbents over pure-value or highly levered spirits peers. A consumer trading down to smaller formats and promotion-led buys tends to preserve household penetration but compresses gross margin and weakens brand equity, so the next leg of risk is not just volume but promo intensity bleeding into the whole aisle. That makes the setup more negative for branded spirits with heavier on-premise exposure and less flexible price architecture than the company highlighted here.

The on-trade comment matters because it suggests the weaker channel is not uniformly the one with the best recovery potential; if socializing is improving, then operators with stronger bar/restaurant exposure should outperform in the next 1-2 quarters, while off-premise-heavy names remain stuck with affordability pressure and pantry-depletion dynamics. The “inventory adjustment” language also implies the reported full-year comp could remain worse than sell-through for another 1-2 quarters, which is a trap for investors who buy the first sequential improvement. A real inflection likely requires either easier comparisons after the prior tariff distortion or a broader consumer confidence rebound, neither of which is imminent.

The geopolitical overhang is more consequential for travel retail than for domestic spirits: if Middle East disruption persists, travel retail weakness can spill into DTC and airport-adjacent premiumization, which is where mix is highest. That is a second-order margin hit because these channels subsidize premium brand visibility and launch economics; weaker travel flow can therefore pressure the innovation payback period even if launch cadence remains strong. On M&A, ongoing talks introduce optionality, but the more interesting signal is defensive consolidation pressure in a category facing sub-scale economics and slower organic growth.

Contrarian view: the market may be over-discounting the US slowdown as structural when management is explicitly pointing to affordability and inventory normalization, both of which are cyclical and reversible. The better trade is not to fade the whole sector indiscriminately, but to separate brands with genuine pricing power and international mix from those dependent on US off-premise momentum and promotion depth. In the next 3-6 months, the key catalyst is whether Q4 promo spend can stabilize volumes without further margin dilution; if not, earnings revisions likely keep drifting lower into the August print.

Key Decisions for Investors

• Short BF.B tactically into the next 4-8 weeks if it rallies on M&A headlines; use a tight stop above deal-speculation-driven highs. Risk/reward favors downside if the market is extrapolating optionality faster than underlying US spirits demand can recover.
• Pair trade: long a premium on-premise recovery beneficiary in consumer/alcohol exposure versus short BF.B for 1-2 quarters. The thesis is that improving socialization helps bar-exposed names before off-premise inventory clears, creating a relative earnings divergence.
• Avoid buying the broader spirits group on the first sequential improvement in US trends; wait for at least one quarter of sell-through stabilization after promo normalization. Near-term upside is likely offset by margin dilution from smaller packs and heavier discounting.
• For longer-dated relative value, look at a barbell of quality global branded beverage names with diversified geography against domestically concentrated spirits exposure. The risk/reward improves only if US affordability pressures ease materially or the company proves it can hold volume without escalating promotions.
• If Brown-Forman deal chatter intensifies, consider a short-dated call spread hedge rather than outright long exposure. The optionality is real, but headline-driven upside is likely capped until financing terms and synergy assumptions are visible.